18th May 2006 11:21
Cambridge Antibody Tech Group PLC18 May 2006 Page 1 of 1 FOR IMMEDIATE RELEASE Thursday 18th May 2006 For further information contact: Cambridge Antibody Technology Hogarth (Europe)Tel: +44 (0) 1223 471 471 Tel: +44 (0) 20 7357 9477Peter Chambre, Chief Executive Officer Melanie Toyne-SewellJohn Aston, Chief Financial Officer Andrew JaquesRowena Gardner, Director of CorporateCommunications BMC Communications/The Trout Group(USA) Tel: 001 212 477 9007 Brad Miles, ext 17 (media) Brandon Lewis, ext 15 (investors) NOTIFICATION OF RESULTS Cambridge, UK... Cambridge Antibody Technology Group plc ("CAT") (LSE: CAT;NASDAQ: CATG) will be announcing its interim results at 7am BST on Monday 22 May2006. Following the recent announcement of the recommended cash offer byAstraZeneca International plc for CAT, the Company will be issuing a shortenedinterims statement reflecting the Company's present position, but will not beholding a group meeting or conference call for analysts on the day. - ENDS - This information is provided by RNS The company news service from the London Stock ExchangeRelated Shares:
CATCoAstrazeneca